Drug Side Effects
Search
PARATHYROID HYPERPLASIA
PARATHYROID HYPERPLASIA
was reported 56 times
PARATHYROID HYPERPLASIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Vitamin D3 Analog [EPC]
7
0.0003
1
Vitamin D2 Analog [EPC]
2
0.0003
2
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
4
0.0002
3
Vitamin D Analog [EPC]
2
0.0001
4
Histamine-1 Receptor Antagonist [EPC]
7
0.0001
5
Xanthine Oxidase Inhibitor [EPC]
13
0.0001
6
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
1
0.0001
7
Antimetabolite Immunosuppressant [EPC]
1
0.0000
8
Dihydropyridine Calcium Channel Blocker [EPC]
11
0.0000
9
beta-Adrenergic Blocker [EPC]
8
0.0000
10
Hepatitis C Virus NS5A Inhibitor [EPC]
1
0.0000
11
Insulin Analog [EPC]
9
0.0000
12
CD20-directed Cytolytic Antibody [EPC]
6
0.0000
13
Calcium [EPC]
2
0.0000
14
Azole Antifungal [EPC]
2
0.0000
15
Corticosteroid [EPC]
13
0.0000
16
Nonsteroidal Anti-inflammatory Drug [EPC]
13
0.0000
17
RANK Ligand Inhibitor [EPC]
2
0.0000
18
HMG-CoA Reductase Inhibitor [EPC]
3
0.0000
19
Interleukin-6 Receptor Antagonist [EPC]
1
0.0000
20
Platelet Aggregation Inhibitor [EPC]
4
0.0000
21
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
22
Proton Pump Inhibitor [EPC]
3
0.0000
23
Thiazide Diuretic [EPC]
1
0.0000
24
Loop Diuretic [EPC]
2
0.0000
25
GLP-1 Receptor Agonist [EPC]
1
0.0000
26
Atypical Antipsychotic [EPC]
1
0.0000
27
Kinase Inhibitor [EPC]
1
0.0000
28
Tumor Necrosis Factor Blocker [EPC]
1
0.0000